Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).
Kretschmer JR, Tkachenko D, Kümpfel T, Havla J, Engels D, Paul F, Schindler P, Bellmann-Strobl J, Berthele A, Giglhuber K, Zappe C, Klotz L, Revie L, Dawin E, Senel M, Tumani H, Bergh FT, Warnke C, Kraemer M, Walter A, Bayas A, Zettl UK, Lauenstein AS, Yalachkov Y, Etgen T, Kaste M, Luessi F, Gingele S, Passoke S, Weber MS, Sieb JP, Haarmann A, Oschmann P, Rothhammer V, Geis C, Kowarik MC, Kern P, Grothe M, Stephanik H, Angstwurm K, Hoffmann F, Wallwitz U, Wildemann B, Jarius S, Stellmann JP, Pakeerathan T, Schwake C, Ayzenberg I, Kleiter I, Fischer K, Aktas O, Ringelstein M, Häußler V, Trebst C, Hümmert MW.
Kretschmer JR, et al. Among authors: sieb jp.
Front Immunol. 2025 Apr 11;16:1575613. doi: 10.3389/fimmu.2025.1575613. eCollection 2025.
Front Immunol. 2025.
PMID: 40292288
Free PMC article.